Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia.
Wüstenberg, T
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. [electronic resource] - Molecular psychiatry Jan 2011 - 26-36, 1 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1476-5578
10.1038/mp.2010.51 doi
Adult
Analysis of Variance
Atrophy--drug therapy
Attention--drug effects
Brain--drug effects
Double-Blind Method
Erythropoietin--administration & dosage
Humans
Male
Memory--drug effects
Middle Aged
Neuroprotective Agents--administration & dosage
Recombinant Proteins
Schizophrenia--drug therapy
Treatment Outcome
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia. [electronic resource] - Molecular psychiatry Jan 2011 - 26-36, 1 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1476-5578
10.1038/mp.2010.51 doi
Adult
Analysis of Variance
Atrophy--drug therapy
Attention--drug effects
Brain--drug effects
Double-Blind Method
Erythropoietin--administration & dosage
Humans
Male
Memory--drug effects
Middle Aged
Neuroprotective Agents--administration & dosage
Recombinant Proteins
Schizophrenia--drug therapy
Treatment Outcome